Find and Pitch Jounalists, Get Your Story Covered

Tags: Addiction health addiction | drug development | opioids | Pharmaceuticals | public health | STAT Breakthrough Summit art history drug addiction

	Profile	Recent Articles on Subject
1	Vox Staff Vox World explained. techdigital cultureentertainment	Welcome to the Drug Issue of The Highlight - 20 days ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	More evidence on GLP-1s and opioid addiction - about 1 month ago Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch - 11 months ago
3	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	Lyra Health Expands Substance Use Disorder Support - about 2 months ago
4	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Just How Addictive Is the Drug That Killed Matthew Perry? - 3 months ago
5	Kristen Monaco MedPage Today	More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 3 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 9 months ago U.S. Suicides Hit Record High; FDA Reviews Schizophrenia Drug; Psychology of Misinfo - 12 months ago ADHD and Dementia; Alleged Sex Assault in MDMA Trial; iPhones Screen for Depression - about 1 year ago Schizophrenia Sexual Dysfunction; Nuplazid Box Warning Tweak; Psych Practice Fraud? - about 1 year ago
6	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 3 months ago A tough week for MDMA-assisted psychotherapy - 3 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 4 months ago
7	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The FDA Just Rejected a Bid for MDMA to Treat PTSD - 4 months ago
8	Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York consciousnesseconomicspodcasting	MDMA therapy didn’t get FDA approval. Now what? - 4 months ago
9	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Neuro drugs are still faltering, despite rising investment - 4 months ago Despite adcomm rejection, Lykos CEO sees future for MDMA drug - 5 months ago
10	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	FDA finalizes guidance on studying opioid use disorder treatments - 5 months ago Physicians ask FDA to revoke approval of DNA test for opioid addiction - 8 months ago Physicians ask FDA to revoke approval of DNA test for opioid addiction - 8 months ago

Journalists covering drugs & addiction